Advancing the Science of Immuno-Oncology
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative and proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.
Based in Seattle, Washington, the company is notable for its empowering work environment, entrepreneurial culture, proprietary platform technologies and success in recruiting some of the most innovative minds in the industry.
Two clinical candidates. Three preclinical candidates. All in development to improve outcomes for cancer patients.